Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients
What is the purpose of this trial?
The purpose of the study will be to evaluate the efficacy of mecamylamine in reducing alcohol consumption in smoking and non-smoking alcohol dependent patients.
We hypothesize that mecamylamine will result in a greater reduction of alcohol consumption than placebo. We further hypothesize that mecamylamine will be effective in reducing both alcohol consumption and smoking in a subset of alcoholics who also smoke.
- 18 Years - 60 Years
- Elizabeth Ralevski
- May 2004
- Last Updated:
- April 16, 2013
- Study HIC#:
Clinicaltrials.gov ID: NCT00342563